newsfilter
← Latest News
PR Newswire·

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...